SRPT vs TVTX · rev $1.13B vs rev $296.8M
Sarepta Therapeutics Inc (SRPT) versus Travere Therapeutics Inc (TVTX) — a side-by-side from cached financials, not a winner call.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Travere Therapeutics Inc (TVTX) is a biotechnology company listed on US.
Latest reported SRPT revenue for 2026-06-30 was $1.13B. Net income was $326.1M. Revenue was up 54.9% from 2026-03-31 to 2026-06-30. SRPT currently screens at market cap $2.34B.
Latest reported TVTX revenue for 2026-06-30 was $296.8M. Net income was -$71.9M. TVTX currently screens at market cap $1.33B.
SRPT currently screens at market cap $2.34B. TVTX currently screens at market cap $1.33B.
Not investment advice. Open the SRPT and TVTX stock pages for the full models.
Not investment advice.